the eu drug treatments company says it's evaluating even if to authorize booster doses of Johnson & Johnson’s single-shot COVID-19 vaccine
ByThe associated Press
November 22, 2021, 2:04 PM
• 2 min read
Share to FacebookEmail this textAMSTERDAM -- the european drug treatments company says it's evaluating even if to authorize booster doses of Johnson & Johnson's single-shot COVID-19 vaccine.
In an announcement Monday, the eu drug regulator mentioned it become considering that an software from J&J to advocate booster doses of the J&J vaccine for adults 18 and over, at least two months after they had been first immunized. Amid an explosive surge of new coronavirus infections across Europe, the EMA noted it anticipated to make a choice on this inside weeks.
The U.S. meals and Drug Administration gave the green gentle to J&J booster doses in October, each for people who originally bought the J&J and vaccine and for people who obtained immunized with different vaccines.
J&J previous introduced effects from a large analyze that found giving a 2nd dose simply two months after the first bumped insurance plan in opposition t symptomatic COVID-19 to 94% from 70% in U.S. recipients. Giving that booster six months later as a substitute brought about an excellent larger bounce in virus-combating antibodies.
european nations in the beginning ordered about 200 million doses of J&J's vaccine, but handiest a fraction were delivered after the company has confronted repeated creation issues.
The EMA has in the past talked about its 27 countries could consider administering booster doses of vaccines made by Pfizer-BioNTech and Moderna for americans who had received both-dose regimens as a minimum six months earlier than, noting that a 3rd shot would provide additional antibodies against COVID-19. The agency is expected to make a decision later this week on COVID-19 vaccines for babies aged 5 to eleven.
â€"â€"â€"
read full AP insurance of the pandemic at: https://apnews.com/hub/coronavirus-pandemic
0 Comments